Carafate and Lenalidomide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Carafate (sucralfate) and Lenalidomide (lenalidomide). Common drug interactions include vomiting among females and haemoglobin decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Carafate and Lenalidomide. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Carafate?

Carafate has active ingredients of sucralfate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 14,028 Carafate users. Check the latest studies of Carafate.

What is Lenalidomide?

Lenalidomide has active ingredients of lenalidomide. eHealthMe is studying from 52,881 Lenalidomide users. Check the latest studies of Lenalidomide.

On Jul, 07, 2026

20 people who take Carafate and Lenalidomide together, and have interactions are studied.

Carafate and Lenalidomide drug interactions.

What are the common drug interactions of Carafate and Lenalidomide, by gender? *:

female:

Vomiting
Drug intolerance (drug sensitivity)
Nausea (feeling of having an urge to vomit)
Plasma cell myeloma (cancer that begins in plasma cells)
Anaemia (lack of blood)
Dyspnoea exertional (breathlessness or shortness of breath)
Cough
Pruritus (severe itching of the skin)
Urticaria (rash of round, red welts on the skin that itch intensely)
Wheezing (a high-pitched whistling sound made while you breath)

male:

Haemoglobin decreased
Platelet count decreased
Large intestinal haemorrhage (bleeding in large intestine)
Lower respiratory tract inflammation
Osteopenia (a condition where bone mineral density is lower than normal)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Rectal haemorrhage (bleeding from anus)
Spinal compression fracture (fracture due to spinal compression on bone)
Thrombosis (formation of a blood clot inside a blood vessel)
White blood cell count decreased

What are the common drug interactions of Carafate and Lenalidomide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Arthralgia (joint pain)
Fatigue (feeling of tiredness)
Gingival pain (gum pain)
Headache (pain in head)
Hot flush (sudden feelings of heat)
Insomnia (sleeplessness)
Malaise (a feeling of general discomfort or uneasiness)
Nausea (feeling of having an urge to vomit)
Nervousness
Pneumonia

60+:

Anaemia (lack of blood)
Dyspnoea exertional (breathlessness or shortness of breath)
Colitis ischaemic (due to infection of intestine impaired blood supply to colon)
Diarrhoea
Diffuse large b-cell lymphoma (cancer of b cells, a type of white blood cell)
Disease progression
Faeces discoloured
Fatigue (feeling of tiredness)
Hospitalisation
Increased upper airway secretion

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 10 people, 50.00%
Nausea (feeling of having an urge to vomit): 3 people, 15.00%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 3 people, 15.00%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 10.00%
Nausea And Vomiting: 2 people, 10.00%
Stress And Anxiety: 1 person, 5.00%
Primary Myelofibrosis (primary disorder of the bone marrow): 1 person, 5.00%
Pain: 1 person, 5.00%
Local Swelling (swelling at the site of some application of substance or injury): 1 person, 5.00%
Itching: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Carafate and Lenalidomide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously